CCR CONSTANCE CARE NewConnect · Annual (jednostkowy - standalone, not consolidated) · publ. May 28, 2026

FY 2024 report

Spolka faktycznie zaprzestala dzialalnosci operacyjnej: przychody spadly z 1,45 mln zl do 84 tys. zl w 2024 r., a w 2025 r. wyniosly 0 zl.

Sentiment

Negative No guidance change

Website

CCR FY 2024 report

Revenue

84,264 PLN

-94.2% YoY

—

Net income

-5,081,312 PLN

-217.6% YoY

—

EBITDA

-3,120,440 PLN

-3307% YoY

—

FCF

-1,927,034 PLN

-5.3% YoY

—

Summary

Investment thesis

Kapitaly wlasne sa ujemne (-2,62 mln zl), co uruchomilo obowiazek zwolania WZA w trybie art. 397 KSH ws. dalszego istnienia spolki.
Niemal caly dlug bankowo-pozyczkowy (13,4 mln zl) jest wedlug noty 41 w calosci wymagalny i przeterminowany po nieudanej probie ukladu restrukturyzacyjnego.
Jedynym twardym aktywem pozostaje nieruchomosc inwestycyjna w Kierszku (9,06 mln zl) i zwiazane z nia srodki trwale (2,89 mln zl), obciazone hipotekami siegajacymi 14,62 mln zl - wiecej niz ksiegowa wartosc zabezpieczenia.
Cala strategia odbudowy (2026-2028) zaklada wejscie niepodpisanego jeszcze inwestora strategicznego oraz transfer dzialalnosci medycznej od dzierzawcy CNR do spolki publicznej - bez tego zalozenia plan nie ma podstaw finansowania.

Read the full analysis

Financial data is open to everyone. The full analysis — management verdict, commentary, risks, and the full narrative — is available after you sign up or log in.

Financials

BETA

FY 2024

CCR · FY 2024

Metric	FY 2024	FY 2023	Δ YoY	Value type	Segment	Conf.

Revenue	84,264	1,454,100	−94.2%	reported	—	1.00
EBITDA	-3,120,440	97,300	−3307%	reported	—	0.95
EBIT	-3,202,924	13,800	−23309.6%	reported	—	1.00
EBT	-5,081,312	-1,599,700	−217.6%	reported	—	1.00
Net income	-5,081,312	-1,599,700	−217.6%	reported	—	1.00
D&A	82,484	83,400	−1.1%	reported	—	1.00
Interest expense	1,859,903	1,629,300	+14.2%	reported	—	1.00

Cash	1,000	15,400	−93.5%	reported	—	1.00
Total debt	13,361,349	11,487,500	+16.3%	reported	—	0.90
Net debt	13,360,348	11,472,100	+16.5%	reported	—	0.90
Equity	-2,623,244	2,458,100	−206.7%	reported	—	1.00
Total assets	12,624,463	15,721,000	−19.7%	reported	—	1.00
Working capital	-2,549,185	-1,641,800	−55.3%	reported	—	0.95
Current assets	8,726	3,005,500	−99.7%	reported	—	1.00
Current liabilities	2,557,911	4,647,300	−45%	reported	—	1.00
Goodwill	0	0	—	reported	—	0.90

CFO	-1,927,034	-1,366,200	−41.1%	reported	—	1.00
CapEx	0	464,200	−100%	reported	—	1.00
FCF	-1,927,034	-1,830,400	−5.3%	reported	—	0.95

Current ratio	0x	650x	−650x	reported	—	0.95
Cash ratio	0x	0x	+0x	reported	—	0.95
Interest coverage	-1.72x	10x	−11.72x	reported	—	0.85

Debt / assets	1.06x	730x	−728.94x	reported	—	0.85

Revenue growth (YoY)	-94.2%	-36900%	—	reported	—	1.00
Net income growth (YoY)	-217.66%	-341100%	—	reported	—	1.00

FY 2024 · Δ YoY

Revenue

84,264 −94.2%

FY 2023: 1,454,100

EBITDA

-3,120,440 −3307%

FY 2023: 97,300

EBIT

-3,202,924 −23309.6%

FY 2023: 13,800

EBT

-5,081,312 −217.6%

FY 2023: -1,599,700

Net income

-5,081,312 −217.6%

FY 2023: -1,599,700

D&A

82,484 −1.1%

FY 2023: 83,400

Interest expense

1,859,903 +14.2%

FY 2023: 1,629,300

Cash

1,000 −93.5%

FY 2023: 15,400

Total debt

13,361,349 +16.3%

FY 2023: 11,487,500

Net debt

13,360,348 +16.5%

FY 2023: 11,472,100

Equity

-2,623,244 −206.7%

FY 2023: 2,458,100

Total assets

12,624,463 −19.7%

FY 2023: 15,721,000

Working capital

-2,549,185 −55.3%

FY 2023: -1,641,800

Current assets

8,726 −99.7%

FY 2023: 3,005,500

Current liabilities

2,557,911 −45%

FY 2023: 4,647,300

Goodwill

0 —

FY 2023: 0

CFO

-1,927,034 −41.1%

FY 2023: -1,366,200

CapEx

0 −100%

FY 2023: 464,200

FCF

-1,927,034 −5.3%

FY 2023: -1,830,400

Current ratio

0x −650x

FY 2023: 650x

Cash ratio

0x +0x

FY 2023: 0x

Interest coverage

-1.72x −11.72x

FY 2023: 10x

Debt / assets

1.06x −728.94x

FY 2023: 730x

Revenue growth (YoY)

-94.2% —

FY 2023: -36900%

Net income growth (YoY)

-217.66% —

FY 2023: -341100%